In high or very high risk prostate cancer, do you utilize combined androgen blockade in patients receiving definitive RT?  

Do you have a preference for bicalutamide? Can abiraterone be used instead?  



Answer from: Radiation Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Stamford Health
Thanks for both answers. Is bicalutamide still wha...
Radiation Oncologist at University of Florida
No.
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice